Enteris BioPharma has premier expertise in formulating solid oral dosage forms with the most challenging APIs.
With vast experience formulating highly potent peptide and small molecule APIs, Enteris is uniquely suited with the know-how and capabilities to bring our clients’ drugs to the clinic as efficiently as possible.
Enteris is equipped with a state-of-the art laboratory with fully integrated preformulation and formulation development capabilities.
Preformulation Development
- Solubility screening
- Proteolysis screening
- Aggregation propensity
- Excipient compatibility screening
- Physical characterization of drug flow
Formulation Development
- Immediate- and modified-release solid oral dosage forms
- Tablets, minitablets, and capsules
- Highly potent API (HPAPI) handling
- Blending
- Wet and dry granulation
- Tablet compression
- Capsule filling
- Aqueous film coating
Differentiated Formulation Expertise
- Robust experience working at minimal batch sizes when drug substance supplies are limited
- Thorough experience formulating HPAPI and achieving excellent content uniformity
- Industry-leading expertise in enteric coatings
